Terms ending in 2035
Every in-force patent on Hoffmann-La Roche Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,004,817 | Diazacarbazole Derivatives as Tau-Pet-Ligands In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,555,067 | Fc-Region Variants with Improved Protein A-Binding In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,398,203 | Method for Producing Bispecific Antibodies Comprising a Y436A Fc-Region Mutation for Improved Protein A-Binding In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 10,005,770 | Process for the Preparation of N-[(3-Aminooxetan-3-YL)METHYL]-2-(1,1-Dioxo-3,5-Dihydro-1,4-Benzothiazepin-4-YL)-6-Methyl-QUINAZOLIN-4-Amine In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 10,358,643 | Poly Oligomer Compound with Biocleavable Conjugates In force · High confidence | Ricc A/S | In force | High confidence | |
| US 9,458,153 | Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,957,266 | IMIDAZO[1,2-a]PYRIDIN-7-Amine In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 10,584,178 | Bispecific HER2 Antibodies and Methods of Use In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,993,564 | Blood Brain Barrier Shuttle In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,233,978 | Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| 56 more term ends in 2035 · Pro | |||||
10 of 66 patents shown. Soonest term end first, then patent number.
Pro members see all 66.
59 of these are in force and held by Hoffmann-La Roche Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.